● Recruiting

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Condition: Advanced Adenocarcinoma · Sponsor: BioAtla, Inc.

PhasePhase 1

Planned participants168

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma

This description comes directly from the study's public registry record.

Talk to the study team

BioAtla Medical Affairs · 858-558-0708 · medicalaffairs@bioatla.com

Always discuss trial participation with your own doctor first.

Locations (9)

UC Irvine	Irvine, California, United States	Recruiting
USC Norris Comprehensive Cancer Center	Los Angeles, California, United States	Recruiting
Yale Cancer Center	New Haven, Connecticut, United States	Recruiting
Northwestern University	Chicago, Illinois, United States	Recruiting
University of Illinois	Chicago, Illinois, United States	Recruiting
Karmanos Cancer Institute	Detroit, Michigan, United States	Recruiting
The Christ Hospital Cancer Center	Cincinnati, Ohio, United States	Recruiting
University Hospitals Cleveland Medical Center	Cleveland, Ohio, United States	Recruiting
Fred Hutch Cancer Center	Seattle, Washington, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05808634